Canada markets closed

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
20.76+0.74 (+3.70%)
At close: 04:00PM EDT
20.34 -0.42 (-2.02%)
After hours: 07:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.00B
Enterprise Value 1.20B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)50.80
Price/Book (mrq)1.90
Enterprise Value/Revenue 33.03
Enterprise Value/EBITDA -2.37

Trading Information

Stock Price History

Beta (5Y Monthly) 1.80
52-Week Change 3-44.99%
S&P500 52-Week Change 322.36%
52 Week High 347.48
52 Week Low 319.37
50-Day Moving Average 326.52
200-Day Moving Average 330.62

Share Statistics

Avg Vol (3 month) 31.54M
Avg Vol (10 day) 31.16M
Shares Outstanding 596.11M
Implied Shares Outstanding 696.11M
Float 894.93M
% Held by Insiders 11.37%
% Held by Institutions 187.27%
Shares Short (Apr 15, 2024) 414.59M
Short Ratio (Apr 15, 2024) 411.91
Short % of Float (Apr 15, 2024) 417.01%
Short % of Shares Outstanding (Apr 15, 2024) 415.18%
Shares Short (prior month Mar 15, 2024) 413.5M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)7,297.44%

Management Effectiveness

Return on Assets (ttm)-22.83%
Return on Equity (ttm)-42.10%

Income Statement

Revenue (ttm)36.27M
Revenue Per Share (ttm)0.41
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -506.32M
Net Income Avi to Common (ttm)-481.19M
Diluted EPS (ttm)-5.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)912.22M
Total Cash Per Share (mrq)9.49
Total Debt (mrq)115.35M
Total Debt/Equity (mrq)10.98%
Current Ratio (mrq)8.66
Book Value Per Share (mrq)11.29

Cash Flow Statement

Operating Cash Flow (ttm)-394.09M
Levered Free Cash Flow (ttm)-268.21M